Combination of pegylated IFN-{alpha}2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

B Simonsson; T Gedde-Dahl; B Markevärn; A Almqvist; M Sinisalo

Combination of pegylated IFN-{alpha}2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

B Simonsson, T Gedde-Dahl, B Markevärn, A Almqvist, M Sinisalo

Research output: Contribution to journal › Article › Scientific › peer-review

174 Citations (Scopus)

Original language	English
Pages (from-to)	3228-3235
Journal	Blood
Volume	118
Issue number	12
Publication status	Published - 2011
Publication type	A1 Journal article-refereed

Access to Document

https://pubmed.ncbi.nlm.nih.gov/21685374

Cite this

@article{be1a6c049d384f7d968b3a490b871ce6,

title = "Combination of pegylated IFN-{alpha}2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia",

author = "B Simonsson and T Gedde-Dahl and B Markev{\"a}rn and A Almqvist and M Sinisalo",

year = "2011",

language = "English",

volume = "118",

pages = "3228--3235",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "12",

}

TY - JOUR

T1 - Combination of pegylated IFN-{alpha}2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

AU - Simonsson, B

AU - Gedde-Dahl, T

AU - Markevärn, B

AU - Almqvist, A

AU - Sinisalo, M

PY - 2011

Y1 - 2011

M3 - Article

SN - 0006-4971

VL - 118

SP - 3228

EP - 3235

JO - Blood

JF - Blood

IS - 12

ER -